Security key
09061G101
BIOMARIN PHARMACEUTICAL INC - Common Stock (BMRN)
CUSIP: 09061G101
Q1 2021 13F Holders as of 31 Mar 2021
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 177,743,163
- Total 13F value
- $13,419,458,431
- Share change
- -3,641,805
- Put/Call ratio
- 150%
- SEC-reported price per share
- $75.51
- Number of holders
- 513
- Value change
- -$323,613,922
- Number of buys
- 241
- Number of sells
- 256
- Shares outstanding
- 192,632,743
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2021
Institutions
513
Top holders
10
BMRN full security history
Ownership snapshot
Full 13F holder table
BIOMARIN PHARMACEUTICAL INC SEC filings
BIOMARIN PHARMACEUTICAL INC company facts
Broader feeds
Ownership snapshot
Top reported holders of BMRN - BIOMARIN PHARMACEUTICAL INC - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Capital Research Global I...
Disclosed value leader
Capital Research Global I...
Comparable rows
0/15
Latest evidence
31 Dec 2020
13F
Highest disclosed value: $1,936,094,000
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Capital Research Global Investors has the largest disclosed position value at $1.94B.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Capital Research Global Investors's linked filing trail.
Disclosed position value
Top 5
Capital Research Global Investors
$1.94B
PRIMECAP MANAGEMENT CO/CA/
$1.59B
VANGUARD GROUP INC
$1.44B
BlackRock Finance, Inc.
$1.29B
DODGE & COX
$859.09M
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Capital Research Global Investors |
13F
Company
|
—
denominator unverified
|
$1,936,094,000
22,078,957 shares
|
— | 31 Dec 2020 |
| PRIMECAP MANAGEMENT CO/CA/ |
13F
Company
|
—
denominator unverified
|
$1,591,395,000
18,147,961 shares
|
— | 31 Dec 2020 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$1,435,458,000
16,369,689 shares
|
— | 31 Dec 2020 |
| BlackRock Finance, Inc. |
13F
Company
|
—
denominator unverified
|
$1,290,284,000
14,714,160 shares
|
— | 31 Dec 2020 |
| DODGE & COX |
13F
Company
|
—
denominator unverified
|
$859,092,000
9,796,924 shares
|
— | 31 Dec 2020 |
| BAKER BROS. ADVISORS LP |
13F
Company
|
—
denominator unverified
|
$665,505,000
7,589,294 shares
|
— | 31 Dec 2020 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2021
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
513
Shares
177,743,163
Rows available
513
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2021 vs Q1 2021 Across Filers
Q1 2021 holders
513
Q1 2021 holders
513
Holder diff
0
| Investor | Q1 2021 Shares | Q1 2021 Shares | Share Diff | Share Chg % | Q1 2021 value | Q1 2021 value | Value change | Value Chg % |
|---|